Analysis of genetic mutations associated with immune-activated microenvironment in lung adenocarcinoma.

被引：0
|
作者：
Liang, Zhen
Zhao, Shuhua
Liu, Danni
Mu, Tianhao
Chen, Jinfeng
机构：
[1] Beijing Canc Hosp, Beijing, Peoples R China
[2] HaploX Biotechnol, Shenzhen, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e20520
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20520
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Immune landscape of the tumor microenvironment to predict prognosis and DNA mutations in patients with lung adenocarcinoma.
    Lee, Sunyoung S.
    Elkhanany, Ahmed
    Baird, Andrew
    Dolan, Jillian
    Lee, Dong Chan
    Park, Shinyoung
    Baird, Stuart
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [2] Better tumor immune microenvironment in patients with older lung adenocarcinoma.
    Wang, Yongjie
    Yang, Ronghua
    Wang, Dong
    Xuan, Yunpeng
    Yu, Yi
    Qi, Yingxue
    Ge, Minghui
    Luo, Ningning
    Zhu, Xiaofeng
    Li, Mengmeng
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [3] Are lung adenocarcinoma mutations shaping the immune microenvironment?
    Rochigneux, Philippe
    Garon, Edward B.
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 : S740 - S742
  • [4] The predictive values of POTEE mutations for response to immune checkpoint inhibitors in lung adenocarcinoma.
    Yang, Yi
    Ren, Fuqiang
    Wang, Yuan
    Yang, Qidong
    Zhao, Lele
    Chen, Lin
    Liu, Yaqin
    Xiao, Mingzhe
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [5] Transcriptional characterization of immune microenvironment and their prediction role for the prognosis of local advanced lung adenocarcinoma.
    Chen, Yuqiao
    Shi, Xinying
    Song, Xue
    Gao, Lingling
    Mao, Beibei
    Zhang, Henghui
    Zhou, Yuan
    Zhuang, Wei
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [6] RIT1 mutations define a new genetic subset of lung adenocarcinoma.
    Berger, Alice
    Imielinski, Marcin
    Duke, Fujiko
    Wala, Jeremiah
    Kaplan, Nathan
    Shi, Geng-Xian
    Andres, Douglas
    Meyerson, Matthew
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [7] Comprehensive analysis of Cuproplasia and immune microenvironment in lung adenocarcinoma
    Kuang, Junjie
    Zheng, Zemao
    Ma, Wen
    Zeng, Shaohui
    Wu, Dehua
    Weng, Xie
    Chen, Yuming
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [8] Cancer cell-intrinsic expression of MHCII regulates the immune microenvironment and response to immune therapy in lung adenocarcinoma.
    Johnson, Amber M.
    Bulock, Bonnie L.
    Neuwelt, Alexander J.
    Schenk, Erin L.
    Clambey, Eric T.
    Nemenoff, Raphael A.
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 41 - 41
  • [9] The tumor immune microenvironment is decisive in the survival of pancreatic ductal adenocarcinoma.
    Aziz, Hosein M.
    Saida, Lawlaw
    de Koning, Willem
    Stubbs, Andrew
    Li, Yunlei
    van Eijck, Casper H. J.
    Mustafa, Dana A. M.
    CANCER RESEARCH, 2021, 81 (22) : 80 - 81
  • [10] Frequency of EGFR mutations in leptomeningeal metastasis of lung adenocarcinoma.
    Jiang, Ben-Yuan
    Yang, Jinji
    Su, Jian
    Chen, Zhihong
    Wu, Yi-Long
    Guo, Weibang
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345